Kovai Medical Center and Hospital Limited has announced the opening of a special window for shareholders to re-lodge physical share transfer requests that were previously rejected or not processed. The company informed BSE Limited about this initiative through a formal communication dated April 13, 2026, along with newspaper advertisements published in English and Tamil.

Special Window Details

Pursuant to SEBI circular No.HO/38/13/11(2)2026-MIRSD-POD/1/3750/2026 dated January 30, 2026, the company has opened this facility for shareholders whose transfer requests faced issues in the past.

Re-lodgement Process

Shareholders are requested to re-lodge their transfer requests with the company by the deadline of February 4, 2027. All submissions should be directed to:

• The Company Secretary
• Kovai Medical Center and Hospital Limited
• 99 Avinashi Road, Coimbatore-641014

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of SEBI (LODR) Regulations 2015. The company published advertisements in:

• Trinity Mirror (English) - April 11, 2026
• Makkal Kural (Tamil) - April 11, 2026

Company Secretary R. Ponmanikandan signed the communication to BSE Limited, ensuring proper regulatory disclosure of this shareholder facility. The initiative demonstrates the company's commitment to resolving pending physical share transfer issues and providing shareholders with an opportunity to complete previously unsuccessful transactions.

Kovai Medical Center and Hospital Limited has announced the successful completion of its postal ballot process for the reappointment of two independent directors. The company submitted the voting results to BSE Limited on April 13, 2026, demonstrating strong shareholder confidence in the proposed appointments.

Voting Results Overview

The postal ballot covered two special resolutions, both receiving overwhelming shareholder support. The remote e-voting process was conducted through the National Securities Depository Limited (NSDL) platform, ensuring transparency and accessibility for all eligible shareholders.

Director Appointments

The first resolution concerned the reappointment of Mr. A.P. Ammasaikutti (DIN: 00909930) as an Independent Director. This resolution received support from 119 members representing 6621901 shares, constituting 99.91% of the total votes cast. Only 14 members holding 5936 shares voted against the proposal.

The second resolution involved the reappointment of Dr. K. Kolandaswamy (DIN: 06702305) as an Independent Director. This appointment garnered even stronger support, with 122 members holding 6625241 shares voting in favor, representing 99.96% approval. A mere 10 members with 2596 shares opposed this resolution.

Voting Process and Participation

The postal ballot notice was issued on March 6, 2026, with the remote e-voting period commencing at 09.00 A.M. on March 13, 2026, and concluding at 05.00 P.M. on April 11, 2026. Members whose names appeared on the Register of Members as of March 6, 2026, were entitled to participate in the voting process.

Participation Summary:

• Total participating members: 133
• Total shares represented: 6627837
• Promoter group participation: 9 members holding 6087035 shares
• Public participation: 124 members holding 540802 shares

Scrutinizer's Report

K. Duraisami, Practicing Company Secretary (M.No. F6792, CP.No.18308), served as the appointed scrutinizer for the postal ballot process. The scrutinizer confirmed that both resolutions were passed as special resolutions with the requisite majority as per Section 114(2) of the Companies Act, 2013.

The votes were unblocked on April 11, 2026, at 06.00 P.M. in the presence of two independent witnesses, Ms. E. Pavithra and Ms. A. Prateeksha, ensuring the integrity of the voting process. The company has made the complete voting results and scrutinizer's report available on its website at www.kmchhospitals.com .

Regulatory Compliance

The postal ballot process was conducted in accordance with Section 108 of the Companies Act, 2013, and Rule 20 & 22 of the Companies (Management and Administration) Rules, 2014. The submission to BSE Limited fulfills the requirements under Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.